SCYNEXIS (SCYX) Competitors $0.80 +0.00 (+0.46%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$0.79 -0.01 (-0.75%) As of 10/3/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SCYX vs. BHST, APLT, GNFT, CHRS, PLX, FBRX, SLS, MIST, ENTA, and NLTXShould you be buying SCYNEXIS stock or one of its competitors? The main competitors of SCYNEXIS include BioHarvest Sciences (BHST), Applied Therapeutics (APLT), GENFIT (GNFT), Coherus Oncology (CHRS), Protalix BioTherapeutics (PLX), Forte Biosciences (FBRX), SELLAS Life Sciences Group (SLS), Milestone Pharmaceuticals (MIST), Enanta Pharmaceuticals (ENTA), and Neoleukin Therapeutics (NLTX). These companies are all part of the "pharmaceutical products" industry. SCYNEXIS vs. Its Competitors BioHarvest Sciences Applied Therapeutics GENFIT Coherus Oncology Protalix BioTherapeutics Forte Biosciences SELLAS Life Sciences Group Milestone Pharmaceuticals Enanta Pharmaceuticals Neoleukin Therapeutics BioHarvest Sciences (NASDAQ:BHST) and SCYNEXIS (NASDAQ:SCYX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations. Do institutionals and insiders have more ownership in BHST or SCYX? 54.4% of SCYNEXIS shares are owned by institutional investors. 4.9% of SCYNEXIS shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer BHST or SCYX? BioHarvest Sciences currently has a consensus price target of $13.67, suggesting a potential upside of 55.83%. Given BioHarvest Sciences' stronger consensus rating and higher possible upside, analysts clearly believe BioHarvest Sciences is more favorable than SCYNEXIS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioHarvest Sciences 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50SCYNEXIS 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is BHST or SCYX more profitable? BioHarvest Sciences has a net margin of -39.95% compared to SCYNEXIS's net margin of -599.05%. SCYNEXIS's return on equity of -43.04% beat BioHarvest Sciences' return on equity.Company Net Margins Return on Equity Return on Assets BioHarvest Sciences-39.95% -11,357.84% -39.94% SCYNEXIS -599.05%-43.04%-28.21% Which has higher valuation and earnings, BHST or SCYX? BioHarvest Sciences has higher revenue and earnings than SCYNEXIS. BioHarvest Sciences is trading at a lower price-to-earnings ratio than SCYNEXIS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioHarvest Sciences$25.19M5.72-$12.91M-$0.70-12.53SCYNEXIS$3.75M8.94-$21.29M-$0.40-2.00 Does the media refer more to BHST or SCYX? In the previous week, SCYNEXIS had 2 more articles in the media than BioHarvest Sciences. MarketBeat recorded 2 mentions for SCYNEXIS and 0 mentions for BioHarvest Sciences. SCYNEXIS's average media sentiment score of 1.11 beat BioHarvest Sciences' score of 0.00 indicating that SCYNEXIS is being referred to more favorably in the news media. Company Overall Sentiment BioHarvest Sciences Neutral SCYNEXIS Positive Which has more volatility & risk, BHST or SCYX? BioHarvest Sciences has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500. Comparatively, SCYNEXIS has a beta of 1.68, indicating that its share price is 68% more volatile than the S&P 500. SummarySCYNEXIS beats BioHarvest Sciences on 10 of the 16 factors compared between the two stocks. Get SCYNEXIS News Delivered to You Automatically Sign up to receive the latest news and ratings for SCYX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SCYX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCYX vs. The Competition Export to ExcelMetricSCYNEXISMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$33.54M$2.61B$6.13B$10.58BDividend YieldN/A52.87%5.65%4.69%P/E Ratio-2.0024.2286.9626.71Price / Sales8.94726.66604.82131.77Price / CashN/A172.1237.9061.31Price / Book0.555.3412.556.55Net Income-$21.29M$32.92M$3.31B$277.50M7 Day Performance-25.58%3.90%4.28%2.42%1 Month Performance-10.11%8.79%6.90%8.63%1 Year Performance-44.44%-3.79%70.54%31.60% SCYNEXIS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCYXSCYNEXIS0.7908 of 5 stars$0.80+0.5%N/A-44.4%$33.54M$3.75M-2.0060News CoveragePositive NewsBHSTBioHarvest SciencesN/A$9.96-8.5%$13.67+37.2%N/A$178.87M$30.19M-14.23N/AGap DownAPLTApplied Therapeutics3.6983 of 5 stars$0.61-50.7%$4.13+574.1%-87.0%$178.57M$460K-1.3630News CoverageHigh Trading VolumeGNFTGENFIT1.4732 of 5 stars$3.65+2.8%$7.00+91.8%-25.7%$177.51M$76.77M0.00120Gap UpCHRSCoherus Oncology4.2114 of 5 stars$1.70+13.3%$4.51+165.4%+57.7%$174.34M$272.21M1.10330News CoveragePLXProtalix BioTherapeutics2.7387 of 5 stars$2.16+4.9%$15.00+594.4%+125.0%$172.22M$61.95M-16.62200FBRXForte Biosciences3.1041 of 5 stars$14.48+4.6%$68.00+369.6%+208.6%$172.07MN/A-0.895Options VolumeSLSSELLAS Life Sciences Group2.2453 of 5 stars$1.56-4.3%$7.00+348.7%+48.4%$171.63M$1M-4.8810News CoveragePositive NewsShort Interest ↓MISTMilestone Pharmaceuticals1.8145 of 5 stars$2.03+1.5%$4.50+121.7%+40.7%$169.99M$1M-2.4230Gap UpENTAEnanta Pharmaceuticals4.0625 of 5 stars$15.16+91.9%$20.20+33.2%-9.5%$168.89M$67.64M-3.51160News CoverageAnalyst ForecastAnalyst RevisionHigh Trading VolumeNLTXNeoleukin TherapeuticsN/A$17.82+2.4%N/A-54.0%$167.47MN/A-5.7390High Trading Volume Related Companies and Tools Related Companies BHST Alternatives APLT Alternatives GNFT Alternatives CHRS Alternatives PLX Alternatives FBRX Alternatives SLS Alternatives MIST Alternatives ENTA Alternatives NLTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCYX) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SCYNEXIS, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SCYNEXIS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SCYX Stock Alerts